Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Obesity is linked to more severe lower urinary tract symptoms.

New methods for measuring dutasteride are effective and reliable.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Carthamus oxyacantha may help treat BPH by inhibiting 5α-reductase.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Finasteride doesn't affect erections much, but may decrease libido in men.

Different methods accurately measure Finasteride in medicines and body fluids.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Finasteride works best in 6 months and lasts 6 years.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Created microspheres show potential for safe and effective use in prostate artery embolization.